Charles River Laboratories | CRL - Capitalisation Boursière

Prix De L'Action
175.78
Variation Quotidienne
0.71 0.41%
Mensuellement
5.02%
Annuel
75.87%
Q2 Prévisions
168.66




Capitalisation Boursière Changement Date
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 11.2B 2.13B 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Bruker USD 7.16B 2.23B 2025-12
Cardinal Health USD 48.83B 11.54B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Cigna USD 73.52B 3.42B 2025-12
Concord Medical Services Hldg CNY 166.72M 11.49M 2026-04
CVS Health USD 100.74B 5.12B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Dentsply International USD 2.28B 251M 2025-12
Elevance Health USD 77.91B 5.15B 2025-12
Galapagos EUR 1.85B 76.44M 2025-12
Hologic USD 16.62B 1.67B 2025-12
Humana USD 30.81B 485M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Incyte USD 19.39B 2.83B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
McKesson USD 101.25B 5.15B 2025-12
Merck EUR 53.3B 5.72B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Quest Diagnostics USD 19.3B 2.01B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
UnitedHealth USD 299.03B 14.21B 2025-12
Veradigm USD 525M 621M 2026-03
Waters USD 22.61B 5.25B 2025-12
West Pharmaceutical Services USD 19.8B 932M 2025-12